JeanFrancois Mouney - Genfit SA Chairman of the Management Board, CEO

GNFTF Stock  USD 2.95  0.00  0.00%   

Chairman

Mr. JeanFrancois Mouney has served as Chairman of the Management Board and Chief Executive Officer of Genfit SA since 2008. Prior to this, he was Chairman of the Management Board of the Company between September 15, 1999 and 2008. He holds a Business Degree from the Paris Business School, and a degree in economics from the Universite Catholique de Lille. From 1979, he has created, managed and developed several companies specialised in high performance materials and in particular in the aeronautical industry. In 1992, he founded MM, a consultancy firm specialised in healthcare economy. He was responsible for carrying out a public feasibility study for an economic development agency in biologyhealthcare in the NordPasdeCalais region, and was appointed Managing Director of the agency when it was launched in 1995. actively involved from 1997 in the Companys incubation, he is cofounder of GENFIT, created in 1999. Chairman of the Management Board since that date, he received, in 2003 and again in 2004, the Entrepreneur of the Year award, organized internationally by Ernst Young, in the New Technology category. He is also Founder and Board Member of Naturalpha, a company created in 2001 specialised in Nutrition Research and Development and in clinical studies he is VicePresident of the research hub Nutrition, Health and Longevity since 2008.
Age 68
Tenure 16 years
Phone33 3 20 16 40 00
Webhttps://www.genfit.com
Mouney is Advisor of Banque de France since 2008.

Genfit SA Management Efficiency

The company has return on total asset (ROA) of 0.1532 % which means that it generated a profit of $0.1532 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.6745 %, meaning that it generated $0.6745 on every $100 dollars invested by stockholders. Genfit SA's management efficiency ratios could be used to measure how well Genfit SA manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 72.05 M in total debt with debt to equity ratio (D/E) of 0.68, which is about average as compared to similar companies. Genfit SA has a current ratio of 6.2, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Genfit SA until it has trouble settling it off, either with new capital or with free cash flow. So, Genfit SA's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Genfit SA sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Genfit to invest in growth at high rates of return. When we think about Genfit SA's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 1 records

CHAIRMAN Age

Dumsia NtsebezaBarloworld Ltd ADR
66
Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. Genfit S.A. was incorporated in 1999 and is headquartered in Loos, France. Genfit operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 134 people. Genfit SA [GNFTF] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC).

Management Performance

Genfit SA Leadership Team

Elected by the shareholders, the Genfit SA's board of directors comprises two types of representatives: Genfit SA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Genfit. The board's role is to monitor Genfit SA's management team and ensure that shareholders' interests are well served. Genfit SA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Genfit SA's outside directors are responsible for providing unbiased perspectives on the board's policies.
Pascal Caisey, Chief Officer
Dean Hum, COO, Chief Scientific Officer and Member of The Executive Board
Thomas Baetz, Chief Officer
Charles Woler, Vice Chairman of the Supervisory Board
Pr Staels, CoFounder Board
JeanChristophe Marcoux, Chief Officer
Pascal Prigent, Chief Officer
Frederic Desdouits, Member of the Supervisory Board
Laurent Lannoo, Corp Affairs
Bart Staels, President of the Scientific Advisory Board, Member of the Management Board
Xavier Buttes, Chairman of the Supervisory Board
JeanFrancois Mouney, Chairman of the Management Board, CEO
Stefanie Magner, Chief Affairs
Florence Sejourne, Member of the Supervisory Board, Representative of Biotech Avenir
Emilie Desodt, VicePres HR
Nathalie Huitorel, Chief Financial and Admin. Officer and Member of The Executive Board
Philippe Moons, Member of the Supervisory Board, Representative of Finorpa

Genfit Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Genfit SA a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Genfit SA in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Genfit SA's short interest history, or implied volatility extrapolated from Genfit SA options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genfit SA. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Complementary Tools for Genfit Pink Sheet analysis

When running Genfit SA's price analysis, check to measure Genfit SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genfit SA is operating at the current time. Most of Genfit SA's value examination focuses on studying past and present price action to predict the probability of Genfit SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genfit SA's price. Additionally, you may evaluate how the addition of Genfit SA to your portfolios can decrease your overall portfolio volatility.
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Please note, there is a significant difference between Genfit SA's value and its price as these two are different measures arrived at by different means. Investors typically determine if Genfit SA is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genfit SA's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.